SLC12A5-AS1: A Potential Drug Target and Biomarker (G109729184)

Target Name: SLC12A5-AS1

NCBI ID: G109729184

SLC12A5-AS1

Other Name(s): SLC12A5 and MMP9 antisense RNA 1

SLC12A5-AS1: A Potential Drug Target and Biomarker

SLC12A5-AS1, also known as SLC12A5 and MMP9 antisense RNA 1, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. SLC12A5 is a member of the SLC gene family, which is known for the production of various proteins that play essential roles in cell signaling and metabolism. MMP9, on the other hand, is a non-proteinase enzyme that is involved in the regulation of matrix metalloproteinases (MMPs), which are a group of enzymes that are involved in the degradation of extracellular matrix (ECM) components.

SLC12A5-AS1 has been shown to play a critical role in the regulation of MMP9 activity and has been identified as a potential drug target. Several studies have shown that SLC12A5-AS1 can inhibit the activity of MMP9 and can also enhance the activity of MMP9 when introduced into cells. These findings suggest that SLC12A5-AS1 may be a useful drug target for the treatment of conditions that involve MMP9 activity, such as fibrosis, cancer, and neurodegenerative diseases.

In addition to its potential as a drug target, SLC12A5-AS1 has also been identified as a potential biomarker. The expression of SLC12A5 has been shown to be downregulated in various diseases, including cancer, and has been associated with poor prognosis. Additionally, high expression of SLC12A5 has been shown to be associated with the development of certain diseases, such as neurodegenerative diseases. These findings suggest that SLC12A5-AS1 may be a useful biomarker for the diagnosis and prognosis of various diseases.

SLC12A5-AS1 has also been shown to have a role in the regulation of cellular processes that are important for cell survival and proliferation. For example, SLC12A5-AS1 has been shown to play a role in the regulation of cell adhesion, a process that is critical for the maintenance of tissue structure and function. Additionally, SLC12A5-AS1 has been shown to play a role in the regulation of cell signaling pathways, including the TGF-β pathway, which is involved in cell growth, differentiation, and survival.

In conclusion, SLC12A5-AS1 is a non-coding RNA molecule that has been shown to play a critical role in the regulation of MMP9 activity and has potential as a drug target and biomarker. Further studies are needed to fully understand the mechanisms of SLC12A5-AS1 and its potential as a drug and biomarker.

Protein Name: SLC12A5 And MMP9 Antisense RNA 1

The "SLC12A5-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC12A5-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets